Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ)
CNY 32.71
(-0.58%)
CNY 32.71
(-0.58%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 580.06 Million CNY | -8.95% |
| 2022 | 637.09 Million CNY | 19.37% |
| 2021 | 533.72 Million CNY | 776.9% |
| 2020 | 60.86 Million CNY | -91.49% |
| 2019 | 715.2 Million CNY | -50.95% |
| 2018 | 1.45 Billion CNY | 0.44% |
| 2017 | 1.45 Billion CNY | 3.97% |
| 2016 | 1.39 Billion CNY | 10.31% |
| 2015 | 1.26 Billion CNY | 21.45% |
| 2014 | 1.04 Billion CNY | 25.51% |
| 2013 | 830.41 Million CNY | 30.74% |
| 2012 | 635.16 Million CNY | 56.73% |
| 2011 | 405.24 Million CNY | 14.05% |
| 2010 | 355.31 Million CNY | 64.69% |
| 2009 | 215.74 Million CNY | 84.49% |
| 2008 | 116.94 Million CNY | 59.89% |
| 2007 | 73.13 Million CNY | 113.61% |
| 2006 | 34.23 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 165.62 Million CNY | 15.15% |
| 2024 Q2 | 143.82 Million CNY | -28.18% |
| 2024 Q1 | 200.26 Million CNY | 98.5% |
| 2023 Q4 | 100.89 Million CNY | -28.72% |
| 2023 Q2 | 126.67 Million CNY | -39.95% |
| 2023 Q1 | 210.94 Million CNY | 116.43% |
| 2023 Q3 | 141.55 Million CNY | 11.74% |
| 2023 FY | 580.06 Million CNY | -8.95% |
| 2022 Q1 | 237.37 Million CNY | 67.42% |
| 2022 Q4 | 97.46 Million CNY | -49.06% |
| 2022 Q3 | 191.32 Million CNY | 72.71% |
| 2022 FY | 637.09 Million CNY | 19.37% |
| 2022 Q2 | 110.77 Million CNY | -53.33% |
| 2021 Q2 | 81.87 Million CNY | -47.2% |
| 2021 Q1 | 155.05 Million CNY | 175.05% |
| 2021 Q3 | 155.01 Million CNY | 89.33% |
| 2021 Q4 | 141.78 Million CNY | -8.53% |
| 2021 FY | 533.72 Million CNY | 776.9% |
| 2020 Q3 | 70.86 Million CNY | 52.3% |
| 2020 Q4 | -206.61 Million CNY | -391.57% |
| 2020 FY | 60.86 Million CNY | -91.49% |
| 2020 Q1 | 150.09 Million CNY | 8714.89% |
| 2020 Q2 | 46.53 Million CNY | -69.0% |
| 2019 Q2 | 310.97 Million CNY | -3.3% |
| 2019 FY | 715.2 Million CNY | -50.95% |
| 2019 Q1 | 321.58 Million CNY | 4.34% |
| 2019 Q3 | 84.37 Million CNY | -72.87% |
| 2019 Q4 | -1.74 Million CNY | -102.06% |
| 2018 Q2 | 374.36 Million CNY | -9.86% |
| 2018 Q4 | 308.21 Million CNY | -14.46% |
| 2018 FY | 1.45 Billion CNY | 0.44% |
| 2018 Q1 | 415.32 Million CNY | 16.06% |
| 2018 Q3 | 360.31 Million CNY | -3.75% |
| 2017 Q3 | 363.63 Million CNY | 2.72% |
| 2017 Q2 | 353.98 Million CNY | -5.96% |
| 2017 FY | 1.45 Billion CNY | 3.97% |
| 2017 Q1 | 376.42 Million CNY | 5.49% |
| 2017 Q4 | 357.84 Million CNY | -1.59% |
| 2016 Q2 | 336.51 Million CNY | -5.96% |
| 2016 FY | 1.39 Billion CNY | 10.31% |
| 2016 Q4 | 356.83 Million CNY | 3.36% |
| 2016 Q1 | 357.83 Million CNY | 5.24% |
| 2016 Q3 | 345.23 Million CNY | 2.59% |
| 2015 Q2 | 305.5 Million CNY | -2.57% |
| 2015 FY | 1.26 Billion CNY | 21.45% |
| 2015 Q4 | 340 Million CNY | 10.81% |
| 2015 Q3 | 306.83 Million CNY | 0.44% |
| 2015 Q1 | 313.57 Million CNY | 7.79% |
| 2014 FY | 1.04 Billion CNY | 25.51% |
| 2014 Q4 | 290.9 Million CNY | 13.57% |
| 2014 Q1 | 254.16 Million CNY | 6.89% |
| 2014 Q3 | 256.14 Million CNY | 6.24% |
| 2014 Q2 | 241.09 Million CNY | -5.14% |
| 2013 Q2 | 190.91 Million CNY | -5.45% |
| 2013 FY | 830.41 Million CNY | 30.74% |
| 2013 Q4 | 237.77 Million CNY | 19.0% |
| 2013 Q3 | 199.8 Million CNY | 4.66% |
| 2013 Q1 | 201.92 Million CNY | 0.89% |
| 2012 Q1 | 126.01 Million CNY | 5.85% |
| 2012 FY | 635.16 Million CNY | 56.73% |
| 2012 Q2 | 126.06 Million CNY | 0.04% |
| 2012 Q3 | 182.94 Million CNY | 45.12% |
| 2012 Q4 | 200.14 Million CNY | 9.4% |
| 2011 Q2 | 90.06 Million CNY | -14.77% |
| 2011 Q1 | 105.67 Million CNY | 4.53% |
| 2011 FY | 405.24 Million CNY | 14.05% |
| 2011 Q4 | 119.04 Million CNY | 31.6% |
| 2011 Q3 | 90.46 Million CNY | 0.44% |
| 2010 Q1 | 87.68 Million CNY | 11.65% |
| 2010 Q2 | 89.67 Million CNY | 2.27% |
| 2010 Q3 | 76.86 Million CNY | -14.29% |
| 2010 Q4 | 101.08 Million CNY | 31.52% |
| 2010 FY | 355.31 Million CNY | 64.69% |
| 2009 Q1 | 39.09 Million CNY | 29.24% |
| 2009 Q2 | 48.55 Million CNY | 24.22% |
| 2009 Q3 | 49.55 Million CNY | 2.05% |
| 2009 FY | 215.74 Million CNY | 84.49% |
| 2009 Q4 | 78.54 Million CNY | 58.49% |
| 2008 Q3 | 33.88 Million CNY | 0.0% |
| 2008 FY | 116.94 Million CNY | 59.89% |
| 2008 Q4 | 30.24 Million CNY | -10.74% |
| 2007 FY | 73.13 Million CNY | 113.61% |
| 2006 FY | 34.23 Million CNY | 0.0% |